We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Kit Provides Quantitative Determination of Haptoglobin in Human Serum

By LabMedica International staff writers
Posted on 27 Jan 2011
A new liquid stable haptoglobin kit provides a highly sensitive and specific method for the quantitative determination of haptoglobin in human serum.

The method is fully automated and suitable for use on the RX series of bench top clinical analyzers including the RX daytona and RX imola. More...
Liquid, ready-to-use quality controls and calibrators are also available. Liquid specific protein controls are stable for 30 days at 2 °C to 8 °C and are 100% human in origin. Three clinically significant levels are available with assayed target values and ranges for 27 different analytes including haptoglobin.

A product of Randox (Crumlin, UK) the haptoglobin assay is based on an immunoturbidimetric method where haptoglobin in the sample is diluted and reacted with specific antiserum, yielding insoluble aggregates that can be measured turbidimetrically at 340 nm.

A wide measuring range of 0.13 g/L to 3.68 g/L ensures that the assay is capable of accurately measuring above and below the patient normal range while an extended onboard stability of 28 days minimizes reagent waste.

The assay is precise, traceable to certified reference material, and has limited interference from bilirubin, hemoglobin, and triglycerides. Prozone effects are not demonstrated up to at least 7.64 g/L and the assay shows excellent correlation to standard methods.

In addition to quality controls, Randox also offers a specific protein EQA program providing customers with a complete quality management solution. The bi-weekly RIQAS program comprises 26 proteins and allows assessment of analytical performance in comparison to other laboratories using the same method/instrument.

Haptoglobin is an acute phase protein made primarily in the liver. Its main function is to bind free hemoglobin and remove it from circulation preventing damage to the kidneys and loss of iron following hemolysis.

Measurements of haptoglobin are mainly used to diagnose hemolytic anemia and to distinguish it from other types of anemia. In cases of hemolytic anemia, haptoglobin levels in the blood decrease significantly. However, low levels may also indicate red blood cell destruction due to sickle cell anemia or thalassemia.

As an acute phase reactant, haptoglobin levels in the blood are significantly increased in response to infection, inflammation, burns, surgery, and trauma, but haptoglobin is not generally used to diagnose or monitor these conditions.

Related Links:

Randox



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.